Back to Blog

Vancomycin

By Dr. Josephine Ambruzs

May 17, 2017

In this episode of Frontline Research Minute, we will briefly review the results of a recent meta-analysis examining the risk of AKI attributable to intravenous vancomycin. Article link: www.ncbi.nlm.nih.gov/pubmed/27895134.

Tags:

Quick note: This post is to be used for informational purposes only and does not constitute medical or health advice. Each person should consult their own doctor with respect to matters referenced. Arkana Laboratories assumes no liability for actions taken in reliance upon the information contained herein.